These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9170884)

  • 1. [A case report of drug induced hepatitis and pancreatitis].
    Shimizu A; Koyama M; Miyazaki K; Tagawa S; Takase K; Nakano T; Tameda Y; Kosaka Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 May; 94(5):351-5. PubMed ID: 9170884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholestatic hepatitis from ticlopidine].
    Torrano Larrión F
    Aten Primaria; 1999 Jun; 24(2):115. PubMed ID: 10432757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ticlopidine-induced cholestatic hepatitis. A case report].
    López P; Castiella A; Bujanda L; Arenas JI
    Rev Esp Enferm Dig; 1995 Oct; 87(10):735-7. PubMed ID: 8519541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic hepatitis by ticlopidine. Three new cases].
    Artímez ML; Fernández E; Rodríguez M; González M; Rodrigo L
    Rev Esp Enferm Dig; 1997 Oct; 89(10):796-7. PubMed ID: 9424112
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced hepatotoxicity.
    Podda M; Benetti A
    Ann Ital Med Int; 2002; 17(4):213-4. PubMed ID: 12532558
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature.
    Grieco A; Vecchio FM; Greco AV; Gasbarrini G
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):713-5. PubMed ID: 9744703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-infantile giant cell hepatitis. Clinical and histological response to immunosuppressive therapy].
    Pittau S; Morelli S; Venturini E; Boldorini R; Sartori M
    Recenti Prog Med; 1998 Mar; 89(3):126-9. PubMed ID: 9586424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible pancreatitis, hepatitis, and peripheral polyneuropathy associated with parenteral gold therapy.
    Ben-Ami H; Pollack S; Nagachandran P; Lashevsky I; Yarnitsky D; Edoute Y
    J Rheumatol; 1999 Sep; 26(9):2049-50. PubMed ID: 10493691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of olanzapine-induced hypersensitivity syndrome.
    Raz A; Bergman R; Eilam O; Yungerman T; Hayek T
    Am J Med Sci; 2001 Feb; 321(2):156-8. PubMed ID: 11217818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report].
    Kowalski R; Dropiński J; Brzostek T; Szot P; Rzeszutko M; Kasper M; Sawicka A; Szczeklik A
    Kardiol Pol; 2008 Jul; 66(7):758-60. PubMed ID: 18690567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ticlopidine-induced hepatitis. Report of a new case].
    Rivera Vaquerizo P; Solís García del Pozo J; Villanueva Hernández P
    An Med Interna; 2002 Feb; 19(2):99-100. PubMed ID: 11989110
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticlopidine-induced hepatitis.
    Chen LK; Hsieh BH; Chen WC; Tsai ST; Hou MC
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):59-63. PubMed ID: 11310373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticlopidine-induced severe cholestatic hepatitis.
    Wu MS; Chan P; Lien GS; Cheng YS; Pan S
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):663-6. PubMed ID: 10969455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholestatic hepatitis due to ticlopidine: a report of a new case].
    San Juan Portugal F; Jiménez Saez J; Naya Manchado J; Fuentes Solsona F
    An Med Interna; 1997 Oct; 14(10):540-1. PubMed ID: 9424151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ticlopidine-induced acute cholestatic hepatitis. A case report].
    Gandolfi A; Mengoli M; Rota E; Tolomelli S; Zanghieri G; Bernini MV; Lusetti L
    Recenti Prog Med; 2004 Feb; 95(2):96-9. PubMed ID: 15072394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticlopidine-induced granulomatous hepatitis.
    Ruiz-Valverde P; Zafon C; Segarra A; Ribera R; Piera L
    Ann Pharmacother; 1995 Jun; 29(6):633-4. PubMed ID: 7663041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis due to ticlopidine: a new case].
    Sondag D; Bader R; Claude P; Schreiber M
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):40-1. PubMed ID: 8442652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ticlopidine-induced cholestatic hepatitis].
    Miras Parra FJ; Gómez Jiménez FJ; García Contreras T; Valverde Romera M
    Rev Esp Enferm Dig; 1995 May; 87(5):414-5. PubMed ID: 7626305
    [No Abstract]   [Full Text] [Related]  

  • 19. Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature.
    Iqbal M; Goenka P; Young MF; Thomas E; Borthwick TR
    Dig Dis Sci; 1998 Oct; 43(10):2223-6. PubMed ID: 9790457
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis and pancreatitis due to indalpine].
    Calmus Y; Biour M; Bodin F; Cheymol G; Darnis F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):266-8. PubMed ID: 4007381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.